Suppr超能文献

植物大麻素——除了大麻植物还有其他来源吗?

Phytocannabinoids beyond the Cannabis plant - do they exist?

机构信息

Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.

出版信息

Br J Pharmacol. 2010 Jun;160(3):523-9. doi: 10.1111/j.1476-5381.2010.00745.x.

Abstract

It is intriguing that during human cultural evolution man has detected plant natural products that appear to target key protein receptors of important physiological systems rather selectively. Plants containing such secondary metabolites usually belong to unique chemotaxa, induce potent pharmacological effects and have typically been used for recreational and medicinal purposes or as poisons. Cannabis sativa L. has a long history as a medicinal plant and was fundamental in the discovery of the endocannabinoid system. The major psychoactive Cannabis constituent Delta(9)-tetrahydrocannabinol (Delta(9)-THC) potently activates the G-protein-coupled cannabinoid receptor CB(1) and also modulates the cannabinoid receptor CB(2). In the last few years, several other non-cannabinoid plant constituents have been reported to bind to and functionally interact with CB receptors. Moreover, certain plant natural products, from both Cannabis and other plants, also target other proteins of the endocannabinoid system, such as hydrolytic enzymes that control endocannabinoid levels. In this commentary we summarize and critically discuss recent findings.

摘要

有趣的是,在人类文化进化过程中,人类已经检测到植物天然产物,这些产物似乎能够选择性地靶向重要生理系统的关键蛋白受体。含有此类次生代谢产物的植物通常属于独特的化学分类群,会引起强烈的药理学作用,并且通常被用于娱乐和药用目的或作为毒药。大麻属植物 L. 作为药用植物已有悠久的历史,是发现内源性大麻素系统的基础。主要的精神活性大麻成分 Delta(9)-四氢大麻酚(Delta(9)-THC)强烈激活 G 蛋白偶联大麻素受体 CB(1),并调节大麻素受体 CB(2)。在过去的几年中,已经有报道称其他几种非大麻植物成分也能与 CB 受体结合并发挥功能相互作用。此外,某些植物天然产物,来自大麻和其他植物,也靶向内源性大麻素系统的其他蛋白质,例如控制内源性大麻素水平的水解酶。在这篇评论中,我们总结并批判性地讨论了最近的发现。

相似文献

1
Phytocannabinoids beyond the Cannabis plant - do they exist?
Br J Pharmacol. 2010 Jun;160(3):523-9. doi: 10.1111/j.1476-5381.2010.00745.x.
2
Molecular Pharmacology of Phytocannabinoids.
Prog Chem Org Nat Prod. 2017;103:61-101. doi: 10.1007/978-3-319-45541-9_3.
3
Terpenoids, Cannabimimetic Ligands, beyond the Plant.
Molecules. 2020 Mar 29;25(7):1567. doi: 10.3390/molecules25071567.
4
Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history.
J Ethnopharmacol. 2018 Dec 5;227:300-315. doi: 10.1016/j.jep.2018.09.004. Epub 2018 Sep 8.
5
Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
Pharmacol Res. 2021 Jan;163:105302. doi: 10.1016/j.phrs.2020.105302. Epub 2020 Nov 24.
6
Phytocannabinoids and endocannabinoids.
Curr Drug Abuse Rev. 2009 Jan;2(1):51-75. doi: 10.2174/1874473710902010051.
7
Constituents of Cannabis Sativa.
Adv Exp Med Biol. 2021;1264:1-13. doi: 10.1007/978-3-030-57369-0_1.
9
Phytocannabinoid Pharmacology: Medicinal Properties of Constituents Aside from the "Big Two".
J Nat Prod. 2021 Jan 22;84(1):142-160. doi: 10.1021/acs.jnatprod.0c00965. Epub 2020 Dec 23.
10
Cannabinoids, Phenolics, Terpenes and Alkaloids of .
Molecules. 2021 May 8;26(9):2774. doi: 10.3390/molecules26092774.

引用本文的文献

1
Phytochemical Modulators of Nociception: A Review of Cannabis Terpenes in Chronic Pain Syndromes.
Pharmaceuticals (Basel). 2025 Jul 24;18(8):1100. doi: 10.3390/ph18081100.
4
Effect of Hormonal Treatments on Cannabinoid Content Levels in Female Hemp ( L.) Inflorescences.
Int J Mol Sci. 2025 Apr 7;26(7):3445. doi: 10.3390/ijms26073445.
5
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years.
Pharmaceuticals (Basel). 2025 Feb 18;18(2):266. doi: 10.3390/ph18020266.
6
The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review.
J Neuroimmune Pharmacol. 2025 Feb 3;20(1):12. doi: 10.1007/s11481-025-10171-z.
7
Utilization of Cannabidiol in Post-Organ-Transplant Care.
Int J Mol Sci. 2025 Jan 15;26(2):699. doi: 10.3390/ijms26020699.
10
Natural Products Derived from Cannabis sativa for Pain Management.
Handb Exp Pharmacol. 2025;287:239-263. doi: 10.1007/164_2024_710.

本文引用的文献

1
The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain.
Eur Neuropsychopharmacol. 2014 Apr;24(4):608-20. doi: 10.1016/j.euroneuro.2013.10.008. Epub 2013 Oct 22.
2
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.
Br J Pharmacol. 2010 Jun;160(3):677-87. doi: 10.1111/j.1476-5381.2010.00756.x.
3
Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin.
Biochem Pharmacol. 2010 Jun 15;79(12):1815-26. doi: 10.1016/j.bcp.2010.02.015. Epub 2010 Mar 3.
4
Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.
Curr Med Chem. 2010;17(14):1360-81. doi: 10.2174/092986710790980050.
5
Effects of triterpenes on the immune system.
J Ethnopharmacol. 2010 Mar 2;128(1):1-14. doi: 10.1016/j.jep.2009.12.045. Epub 2010 Jan 14.
6
An examination of anthocyanins' and anthocyanidins' affinity for cannabinoid receptors.
J Med Food. 2009 Dec;12(6):1407-10. doi: 10.1089/jmf.2008.0243.
7
Polyphenols: biological activities, molecular targets, and the effect of methylation.
Curr Mol Pharmacol. 2008 Nov;1(3):233-43. doi: 10.2174/1874467210801030233.
9
Notice of retraction.
J Pharmacol Exp Ther. 2009 Dec;331(3):1147.
10
Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds.
Toxicology. 2010 Nov 28;278(1):88-100. doi: 10.1016/j.tox.2009.11.008. Epub 2009 Nov 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验